Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

Diabetes Care. 2013 Aug;36(8):e119. doi: 10.2337/dc13-0709.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / etiology
  • Female
  • Glucagon / metabolism
  • Humans
  • Hyperglycemia / drug therapy*
  • Middle Aged
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*
  • Werner Syndrome / complications
  • Werner Syndrome / drug therapy*

Substances

  • Pyrazines
  • Triazoles
  • Glucagon
  • Sitagliptin Phosphate